Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 122

1.

Cell type-specific expression and localization of cytochrome P450 isoforms in tridimensional aggregating rat brain cell cultures.

Vichi S, Sandström von Tobel J, Gemma S, Stanzel S, Kopp-Schneider A, Monnet-Tschudi F, Testai E, Zurich MG.

Toxicol In Vitro. 2015 Mar 17. pii: S0887-2333(15)00046-6. doi: 10.1016/j.tiv.2015.03.005. [Epub ahead of print]

PMID:
25795400
2.

Selective inhibition of HDAC8 decreases neuroblastoma growth in vitro and in vivo and enhances retinoic acid-mediated differentiation.

Rettig I, Koeneke E, Trippel F, Mueller WC, Burhenne J, Kopp-Schneider A, Fabian J, Schober A, Fernekorn U, von Deimling A, Deubzer HE, Milde T, Witt O, Oehme I.

Cell Death Dis. 2015 Feb 19;6:e1657. doi: 10.1038/cddis.2015.24.

PMID:
25695609
3.

Quantitative invitro to invivo extrapolation of tissues toxicity.

Hamon J, Renner M, Jamei M, Lukas A, Kopp-Schneider A, Bois FY.

Toxicol In Vitro. 2015 Feb 9. pii: S0887-2333(15)00012-0. doi: 10.1016/j.tiv.2015.01.011. [Epub ahead of print]

PMID:
25678044
4.

Transcriptomics hit the target: Monitoring of ligand-activated and stress response pathways for chemical testing.

Limonciel A, Moenks K, Stanzel S, Truisi GL, Parmentier C, Aschauer L, Wilmes A, Richert L, Hewitt P, Mueller SO, Lukas A, Kopp-Schneider A, Leonard MO, Jennings P.

Toxicol In Vitro. 2015 Jan 13. pii: S0887-2333(14)00251-3. doi: 10.1016/j.tiv.2014.12.011. [Epub ahead of print]

PMID:
25596134
5.

Transcriptomic analysis of untreated and drug-treated differentiated HepaRG cells over a 2-week period.

Savary CC, Jiang X, Aubry M, Jossé R, Kopp-Schneider A, Hewitt P, Guillouzo A.

Toxicol In Vitro. 2015 Jan 5. pii: S0887-2333(14)00268-9. doi: 10.1016/j.tiv.2014.12.019. [Epub ahead of print]

PMID:
25572481
6.

Application of RPTEC/TERT1 cells for investigation of repeat dose nephrotoxicity: A transcriptomic study.

Aschauer L, Limonciel A, Wilmes A, Stanzel S, Kopp-Schneider A, Hewitt P, Lukas A, Leonard MO, Pfaller W, Jennings P.

Toxicol In Vitro. 2014 Oct 23. pii: S0887-2333(14)00194-5. doi: 10.1016/j.tiv.2014.10.005. [Epub ahead of print]

PMID:
25450743
7.

Statistical strategies for averaging EC50 from multiple dose-response experiments.

Jiang X, Kopp-Schneider A.

Arch Toxicol. 2014 Oct 8. [Epub ahead of print]

PMID:
25294322
8.

A sphingosine kinase inhibitor combined with temozolomide induces glioblastoma cell death through accumulation of dihydrosphingosine and dihydroceramide, endoplasmic reticulum stress and autophagy.

Noack J, Choi J, Richter K, Kopp-Schneider A, Régnier-Vigouroux A.

Cell Death Dis. 2014 Sep 25;5:e1425. doi: 10.1038/cddis.2014.384.

PMID:
25255218
9.

Quantitative Emphysema Distribution in Anatomic and Non-anatomic Lung Regions.

Owsijewitsch M, Ley-Zaporozhan J, Kuhnigk JM, Kopp-Schneider A, Eberhardt R, Eichinger M, Heussel CP, Kauczor HU, Ley S.

COPD. 2015 Jun;12(3):257-66. doi: 10.3109/15412555.2014.933950. Epub 2014 Sep 17.

PMID:
25230093
10.

Optimal experimental designs for dose-response studies with continuous endpoints.

Holland-Letz T, Kopp-Schneider A.

Arch Toxicol. 2014 Aug 26. [Epub ahead of print]

PMID:
25155192
11.

Efficacy and toxicity of chemoradiation in patients with anal cancer--a retrospective analysis.

Koerber SA, Slynko A, Haefner MF, Krug D, Schoneweg C, Kessel K, Kopp-Schneider A, Herfarth K, Debus J, Sterzing F.

Radiat Oncol. 2014 May 13;9:113. doi: 10.1186/1748-717X-9-113.

12.

Magnetic resonance imaging detects changes in structure and perfusion, and response to therapy in early cystic fibrosis lung disease.

Wielpütz MO, Puderbach M, Kopp-Schneider A, Stahl M, Fritzsching E, Sommerburg O, Ley S, Sumkauskaite M, Biederer J, Kauczor HU, Eichinger M, Mall MA.

Am J Respir Crit Care Med. 2014 Apr 15;189(8):956-65. doi: 10.1164/rccm.201309-1659OC.

PMID:
24564281
13.

Summarizing EC50 estimates from multiple dose-response experiments: a comparison of a meta-analysis strategy to a mixed-effects model approach.

Jiang X, Kopp-Schneider A.

Biom J. 2014 May;56(3):493-512. doi: 10.1002/bimj.201300123. Epub 2014 Jan 29.

PMID:
24478144
14.

GRHL1 acts as tumor suppressor in neuroblastoma and is negatively regulated by MYCN and HDAC3.

Fabian J, Lodrini M, Oehme I, Schier MC, Thole TM, Hielscher T, Kopp-Schneider A, Opitz L, Capper D, von Deimling A, Wiegand I, Milde T, Mahlknecht U, Westermann F, Popanda O, Roels F, Hero B, Berthold F, Fischer M, Kulozik AE, Witt O, Deubzer HE.

Cancer Res. 2014 May 1;74(9):2604-16. doi: 10.1158/0008-5472.CAN-13-1904. Epub 2014 Jan 13.

15.

Comparison of PET/CT and PET/MRI hybrid systems using a 68Ga-labelled PSMA ligand for the diagnosis of recurrent prostate cancer: initial experience.

Afshar-Oromieh A, Haberkorn U, Schlemmer HP, Fenchel M, Eder M, Eisenhut M, Hadaschik BA, Kopp-Schneider A, Röthke M.

Eur J Nucl Med Mol Imaging. 2014 May;41(5):887-97. doi: 10.1007/s00259-013-2660-z. Epub 2013 Dec 19.

PMID:
24352789
16.

The role of perfusion effects in monitoring of chemoradiotherapy of rectal carcinoma using diffusion-weighted imaging.

Ganten MK, Schuessler M, Bäuerle T, Muenter M, Schlemmer HP, Jensen A, Brand K, Dueck M, Dinkel J, Kopp-Schneider A, Fritzsche K, Stieltjes B.

Cancer Imaging. 2013 Dec 11;13(4):548-56. doi: 10.1102/1470-7330.2013.0045.

17.

Evaluation of the ESUR PI-RADS scoring system for multiparametric MRI of the prostate with targeted MR/TRUS fusion-guided biopsy at 3.0 Tesla.

Roethke MC, Kuru TH, Schultze S, Tichy D, Kopp-Schneider A, Fenchel M, Schlemmer HP, Hadaschik BA.

Eur Radiol. 2014 Feb;24(2):344-52. doi: 10.1007/s00330-013-3017-5. Epub 2013 Oct 3. Erratum in: Eur Radiol. 2014 Apr;24(4):967.

PMID:
24196383
18.

Validation of Fourier decomposition MRI with dynamic contrast-enhanced MRI using visual and automated scoring of pulmonary perfusion in young cystic fibrosis patients.

Bauman G, Puderbach M, Heimann T, Kopp-Schneider A, Fritzsching E, Mall MA, Eichinger M.

Eur J Radiol. 2013 Dec;82(12):2371-7. doi: 10.1016/j.ejrad.2013.08.018. Epub 2013 Aug 23.

PMID:
24016829
19.

Transcriptomic hepatotoxicity signature of chlorpromazine after short- and long-term exposure in primary human sandwich cultures.

Parmentier C, Truisi GL, Moenks K, Stanzel S, Lukas A, Kopp-Schneider A, Alexandre E, Hewitt PG, Mueller SO, Richert L.

Drug Metab Dispos. 2013 Oct;41(10):1835-42. doi: 10.1124/dmd.113.052415. Epub 2013 Aug 2.

20.

MYCN and HDAC2 cooperate to repress miR-183 signaling in neuroblastoma.

Lodrini M, Oehme I, Schroeder C, Milde T, Schier MC, Kopp-Schneider A, Schulte JH, Fischer M, De Preter K, Pattyn F, Castoldi M, Muckenthaler MU, Kulozik AE, Westermann F, Witt O, Deubzer HE.

Nucleic Acids Res. 2013 Jul;41(12):6018-33. doi: 10.1093/nar/gkt346. Epub 2013 Apr 26.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk